AR111761A1 - Un método para purificar un anticuerpo o un fragmento de anticuerpo de este usando cromatografía de afinidad - Google Patents

Un método para purificar un anticuerpo o un fragmento de anticuerpo de este usando cromatografía de afinidad

Info

Publication number
AR111761A1
AR111761A1 ARP180101273A ARP180101273A AR111761A1 AR 111761 A1 AR111761 A1 AR 111761A1 AR P180101273 A ARP180101273 A AR P180101273A AR P180101273 A ARP180101273 A AR P180101273A AR 111761 A1 AR111761 A1 AR 111761A1
Authority
AR
Argentina
Prior art keywords
antibody
antibody fragment
affinity chromatography
purifying
fragment
Prior art date
Application number
ARP180101273A
Other languages
English (en)
Spanish (es)
Inventor
Gyong Ha
- Lee Dong Eok Sik
Yoo Hee Yang
Chung Min Lee
Se Jun Kim
Hong Jai Lee
Jung Min Yoo
Sung Kang
- Kim Kyunghwa Muk
Original Assignee
Cj Healthcare Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Healthcare Corp filed Critical Cj Healthcare Corp
Publication of AR111761A1 publication Critical patent/AR111761A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
ARP180101273A 2017-05-16 2018-05-15 Un método para purificar un anticuerpo o un fragmento de anticuerpo de este usando cromatografía de afinidad AR111761A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20170060535 2017-05-16

Publications (1)

Publication Number Publication Date
AR111761A1 true AR111761A1 (es) 2019-08-14

Family

ID=64603003

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101273A AR111761A1 (es) 2017-05-16 2018-05-15 Un método para purificar un anticuerpo o un fragmento de anticuerpo de este usando cromatografía de afinidad

Country Status (3)

Country Link
KR (1) KR102087823B1 (ko)
AR (1) AR111761A1 (ko)
TW (1) TWI679052B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102209790B1 (ko) * 2018-12-20 2021-02-01 에이치케이이노엔 주식회사 친화성 크로마토그래피를 이용한 백신용 바이러스 정제방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110144311A1 (en) * 2008-08-14 2011-06-16 Rebecca Chmielowski Methods for purifying antibodies using protein a affinity chromatography
TWI596107B (zh) * 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
MX2017005987A (es) * 2014-11-10 2017-06-29 Hoffmann La Roche Anticuerpos anti-interleucina(il)-1beta y metodos de uso.

Also Published As

Publication number Publication date
KR102087823B1 (ko) 2020-03-13
KR20180125899A (ko) 2018-11-26
TWI679052B (zh) 2019-12-11
TW201900257A (zh) 2019-01-01

Similar Documents

Publication Publication Date Title
CL2021001179A1 (es) Anticuerpos específicos para tl1a y ácidos nucleicos que los codifican (divisional de la solicitud no. 201801596).
CL2008003784A1 (es) Anticuerpo humanizado anti proteina e2 del virus de la hepatitis c o un fragmento de union; acido nucleico que lo codifica; vector y celula huesped que comprenden dicho acido nucleico; metodo para producir el anticuerpo; composicion farmaceutica que comprende el anticuerpo
CU24606B1 (es) Moléculas de anticuerpo que se unen a cd73
MX2017001217A (es) Plataforma de purificacion para anticuerpos biespecificos.
CU24568B1 (es) Anticuerpo inhibidor de masp-3
CL2018000226A1 (es) Mezcla de péptidos (divisional solicitud 201601405)
CL2021000028A1 (es) Anticuerpo multiespecifico (divisional de solicitud 937-2020).
PE20170665A1 (es) Anticuerpos anti-tau humanizados
BR112015022260A2 (pt) anticorpo monoclonal, polinucleotídeo, composição farmacêutica, fragmento isolado de tau, uso de um anticorpo, método de triagem de um agente e ácido nucleico
NO20080246L (no) Anti-IGF1R-antistofformuleringer
BR112016016329A8 (pt) método para realizar cromatografia com resina de cromatografia irradiada com radiação gama e processo integrado, fechado, e contínuo para a produção de uma proteína recombinante purificada
EA201792012A1 (ru) Использование щелочных промывочных растворов во время хроматографии для удаления примесей
BR112015022321A2 (pt) método para purificação de uma proteína
CO2020013833A2 (es) Anticuerpo anti-muerte programada-ligando 1 y su uso
CL2017000756A1 (es) Moléculas de unión, especialmente anticuerpos, que se unen a l1cam (cd171)
PE20181176A1 (es) Composiciones biofarmaceuticas
EA202090262A1 (ru) Очистка белка
PE20230381A1 (es) Proteina de union a rgma
EA201991464A1 (ru) АНТИТЕЛО К α-СИНУКЛЕИНУ И ЕГО ПРИМЕНЕНИЕ
AR117418A1 (es) Métodos para la purificación de polipéptidos usando polisorbatos
CL2018003072A1 (es) Anticuerpos anti-basigin humanizados y uso de los mismos.
EA201891990A1 (ru) Слитые белки на основе рекомбинантного фоллистатина и fc-фрагмента и их применение в лечении мышечной дистрофии дюшенна
EA201691834A1 (ru) Новый способ очистки гонадотропина
MX2016017115A (es) Metodos y reactivos para la purificacion de proteinas.
UY38672A (es) Anticuerpo monoclonal que se une específicamente a gitr

Legal Events

Date Code Title Description
FB Suspension of granting procedure